← Back to Search

Participants with Hearing Loss for Sensorineural Hearing Loss

N/A

Waitlist Available

Led By Jinyu Qian, PhD

Research Sponsored by Sonova AG

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 minutes

Awards & highlights

Study Summary

This trial tests different hearing aid frequency response curves to find the best one for users.

Eligible Conditions

Sensorineural Hearing Loss
Bilateral Hearing Loss

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Sound Quality Ratings - Listening Comfort

Sound Quality Ratings - Overall Preference

Secondary outcome measures

Speech Reception Threshold (SRT) Scores

Trial Design

1Treatment groups

Experimental Treatment

Group I: Participants with Hearing LossExperimental Treatment2 Interventions

Individuals with hearing loss that meet the candidacy to wear hearing aids. All interventions are associated with the fitting of binaural hearing aids with various coupling methods. All participants will be assessed under all interventions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Hearing Aid - Variation #1

2023

N/A

~50

Hearing Aid - Standard Curve

2023

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Sonova AGLead Sponsor

78 Previous Clinical Trials

1,847 Total Patients Enrolled

Jinyu Qian, PhDPrincipal InvestigatorSonova AG

7 Previous Clinical Trials

172 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I qualified to become a part of this clinical investigation?

"To be accepted into this trial, subjects must possess sensorineural hearing loss and fit within the age range of 18-99. A maximum of 25 people will be enrolled in the study."

Answered by AI

Does this research endeavor include individuals aged 35 and over?

"The age requirements for this medical trial are 18 years old to 99 years old."

Answered by AI

Does this research endeavor require any additional participants?

"Clinicaltrials.gov reports that the trial, first posted on May 1st 2023 and last updated April 12th 2023 is not currently recruiting patients. Despite this, there are 178 other research initiatives actively enrolling individuals right now."

Answered by AI

Recent research and studies

Otology & NeurotologyJournal

Sound Quality Ratings of Amplified Speech and Music Using a Direct Drive Hearing Aid: Effects of Bandwidth

Vaisberg, Jonathan, Paula Folkeard, Suzanne Levy, Drew Dundas, Sumit Agrawal, and Susan Scollie. 2020. “Sound Quality Ratings of Amplified Speech and Music Using a Direct Drive Hearing Aid: Effects of Bandwidth”. Otology & Neurotology. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/mao.0000000000002915.

Journal of the American Academy of AudiologyJournal

Psychometric Comparison of the Hearing in Noise Test and the American English Matrix Test

Harianawala, Jumana, Jason Galster, and Benjamin Hornsby. 2019. “Psychometric Comparison of the Hearing in Noise Test and the American English Matrix Test”. Journal of the American Academy of Audiology. Georg Thieme Verlag KG. doi:10.3766/jaaa.17112.

Ear & HearingJournal

Characteristics of Real-world Signal to Noise Ratios and Speech Listening Situations of Older Adults with Mild to Moderate Hearing Loss

Wu, Yu-Hsiang, Elizabeth Stangl, Octav Chipara, Syed Shabih Hasan, Anne Welhaven, and Jacob Oleson. 2018. “Characteristics of Real-world Signal to Noise Ratios and Speech Listening Situations of Older Adults with Mild to Moderate Hearing Loss”. Ear & Hearing. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/aud.0000000000000486.

clinicaltrials.govStudy